Hardev Pandha

Hardev Pandha is clinician scientist and Professor of Medical Oncology at the University of Surrey. He heads the University’s Targeted Cancer Therapy research group and is Director of the Surrey Cancer Research Institute. His areas of expertise include the management of patients with urological cancers and malignant melanoma with a key interest in early phase clinical trials involving targeted agents, and the translational aspects of these studies . His research interests centre around various aspects of immune-oncology, understanding the tumour micro-environment and evaluation of oncolytic viruses as cancer therapeutics.